Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate the Protective Function of CMV-MVA Triplex Vaccine in Adult Recipients of Haploidentical Hematopoietic Stem Cell Transplant

NCT04060277 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04060277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04060277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate the Protective Function of CMV-MVA Triplex Vaccine in Adult Recipients of Haploidentical Hematopoietic Stem Cell Transplant
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 27, 2019
Completion date
April 7, 2030
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accelerated phase chronic myelogenous leukemia, bcr-abl1 positive, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic phase chronic myelogenous leukemia, bcr-abl1 positive, hematopoietic and lymphoid cell neoplasm, hodgkin lymphoma, lymphoblastic lymphoma, myelodysplastic syndrome, myelofibrosis, myeloproliferative neoplasm, non-hodgkin lymphoma